M. lignano Tomo-Seq
Mlig455 transcriptome Search Regeneration Regions Sections Download

Data search


search
Exact
Search

Results for MligTC455_51162

Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Annotation
MligTC455_51162 19 0.40 Mlig455_031792

Neo: -

Age: -

 Mlig455_031792 {REF} {Length: 2044} {RNA1509_36146} {RNA1310_58551} {RNA815_37384}

Cumulative graph for MligTC455_51162

Region-enriched expression

Region logFC logCPM Pvalue FDR Specificity
RegionR1 0.353 0.863 0.99992 1.00000
RegionR2 2.065 0.863 0.64402 0.98107
RegionR3 -1.339 0.863 1.00000 1.00000
RegionR4 -0.907 0.863 1.00000 1.00000
RegionR5 -1.439 0.863 1.00000 1.00000
RegionR6 -1.71 0.863 0.99996 1.00000
RegionR7 3.009 0.863 0.11434 0.64102
RegionR8 -0.032 0.863 1.00000 1.00000

Regeneration-enriched expression

Region logFC logCPM PValue FDR Specificity
RegenerationR1 -2.161 0.863 1.00000 1.00000
RegenerationR2 0.682 0.863 0.74070 0.97011
RegenerationR3 1.39 0.863 0.63314 0.92177
RegenerationR4 1.883 0.863 0.48509 0.86142
RegenerationR5 1.384 0.863 0.58659 0.90367
RegenerationR6 1.368 0.863 0.60624 0.87188
RegenerationBL 0.979 0.863 0.71297 1.00000
RegenerationTP -2.809 0.863 1.00000 1.00000


Genes with expression patterns similar to MligTC455_51162

Nr. Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Σ Spearman correlations Int1 Int2 Int3 Reg1 Reg2 Reg3 Annotation
1. MligTC455_51162 19 0.4 Mlig455_031792

Neo: -

Age: -

 2 - - 1.000 - 1.000 - Mlig455_031792 {REF} {Length: 2044} {RNA1509_36146} {RNA1310_58551} {RNA815_37384}
2. MligTC455_45897 33 0.69 Mlig455_008231

Neo: -

Age: -

 ANGPTL2 0.995 - - 0.995 - - - Mlig455_008231 {REF} {Length: 925} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=151.2]} {Human: ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=131, Expect=4e-35]; ENSG00000101280, ANGPT4, angiopoietin 4, [Score=130, Expect=7e-35]; ENSG00000130812, ANGPTL6, angiopoietin like 6, [Score=125, Expect=7e-33]} {Mouse: ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=131, Expect=3e-35]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=130, Expect=6e-35]; ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=128, Expect=3e-34]} {Dmel: FBgn0034160, CG5550, [Score=108, Expect=9e-29]} {RNA1509_26827} {RNA1310_66248} {RNA815_17173.1}
3. MligTC455_42423 63 1.3 Mlig455_041414, Mlig455_041450

Neo: -

Age: -

 DTHD1 0.992 - - 0.992 - - -

Mlig455_041414 {REF} {Length: 3226} {Pfam: Death domain [PF00531.24, score=26.5]} {Human: ENSG00000197057, DTHD1, death domain containing 1, [RH, Score=100, Expect=8e-21]} {Mouse: ENSMUSG00000090326, Dthd1, death domain containing 1, [Score=78.6, Expect=2e-14]} {Smed: dd_Smed_v6_13807_0_1, dd_Smed_v6_13807_0_1, [Score=160, Expect=1e-40]} {RNA1310_77685}

Mlig455_041450 {REF} {Length: 3327} {Pfam: Death domain [PF00531.24, score=26.5]} {Human: ENSG00000197057, DTHD1, death domain containing 1, [RH, Score=98.2, Expect=3e-20]} {Mouse: ENSMUSG00000090326, Dthd1, death domain containing 1, [Score=76.6, Expect=8e-14]} {Smed: dd_Smed_v6_13807_0_1, dd_Smed_v6_13807_0_1, [RH, Score=160, Expect=2e-40]} {RNA1509_58078} {RNA1310_77685} {RNA815_43052}
4. MligTC455_19795 50 1.05 Mlig455_015163, Mlig455_015285

Neo: -

Age: Up-Down-Down

 0.991 - - 0.991 - - -

Mlig455_015163 {REF} {Length: 4537} {TRANSSPLICED} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=183.2]} {Smed: dd_Smed_v6_23771_0_1, dd_Smed_v6_23771_0_1, [RH, Score=366, Expect=7e-119]} {RNA1509_44797} {RNA1310_13221} {RNA815_45407}

Mlig455_015285 {REF} {Length: 4094} {TRANSSPLICED} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=183.3]} {Smed: dd_Smed_v6_23771_0_1, dd_Smed_v6_23771_0_1, [RH, Score=366, Expect=9e-119]} {RNA1509_57431} {RNA1310_13221} {RNA815_45407}
5. MligTC455_36377 39 0.82 Mlig455_032339

Neo: -

Age: -

 0.988 - - 0.988 - - - Mlig455_032339 {REF} {Length: 2133} {Dmel: FBgn0038397, CG10185, [Score=82.0, Expect=8e-16]} {Celegans: WBGene00020254, T05C3.2, [Score=114, Expect=6e-26]}
6. MligTC455_14220 7 0.16 Mlig455_011703, Mlig455_049836

Neo: -

Age: -

 ADORA2A 0.975 - - 0.975 - - -

Mlig455_011703 {REF} {Length: 1346} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=141.2]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=68.3]; Olfactory receptor [PF13853.8, score=19.6]} {Human: ENSG00000128271, ADORA2A, adenosine A2a receptor, [Score=157, Expect=2e-43]; ENSG00000170425, ADORA2B, adenosine A2b receptor, [Score=152, Expect=4e-42]} {Mouse: ENSMUSG00000020178, Adora2a, adenosine A2a receptor, [Score=153, Expect=4e-42]; ENSMUSG00000018500, Adora2b, adenosine A2b receptor, [Score=152, Expect=1e-42]} {Dmel: FBgn0039747, AdoR, Adenosine receptor, [Score=144, Expect=2e-37]} {Celegans: WBGene00011878, ador-1, ADenOsine Receptor homolog, [Score=95.9, Expect=8e-22]} {Smed: dd_Smed_v6_16752_0_1, dd_Smed_v6_16752_0_1, [Score=101, Expect=2e-23]} {RNA1310_66272} {RNA815_52356}

Mlig455_049836 {REF} {Length: 1682} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=139.0]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=71.0]; Olfactory receptor [PF13853.8, score=19.8]} {Human: ENSG00000128271, ADORA2A, adenosine A2a receptor, [Score=155, Expect=2e-42]; ENSG00000170425, ADORA2B, adenosine A2b receptor, [Score=150, Expect=2e-41]} {Mouse: ENSMUSG00000020178, Adora2a, adenosine A2a receptor, [Score=151, Expect=2e-41]; ENSMUSG00000018500, Adora2b, adenosine A2b receptor, [Score=149, Expect=2e-41]} {Dmel: FBgn0039747, AdoR, Adenosine receptor, [Score=144, Expect=2e-37]} {Celegans: WBGene00011878, ador-1, ADenOsine Receptor homolog, [Score=93.6, Expect=5e-21]} {Smed: dd_Smed_v6_16752_0_1, dd_Smed_v6_16752_0_1, [Score=100, Expect=6e-23]} {RNA1310_66272} {RNA815_52356}
7. MligTC455_25416 74 1.53 Mlig455_023019, Mlig455_023116

Neo: -

Age: -

 KCNK18 0.974 - - 0.974 - - -

Mlig455_023019 {REF} {Length: 2752} {Pfam: Ion channel [PF07885.18, score=122.1]; Sodium ion transport-associated [PF06512.15, score=20.3]} {Human: ENSG00000186795, KCNK18, potassium two pore domain channel subfamily K member 18, [Score=100, Expect=1e-22]} {Mouse: ENSMUSG00000040901, Kcnk18, potassium channel, subfamily K, member 18, [Score=106, Expect=8e-25]} {Dmel: FBgn0033257, sand, sandman, [Score=147, Expect=1e-39]} {Celegans: WBGene00010784, twk-48, TWiK family of potassium channels, [Score=157, Expect=1e-43]} {Smed: dd_Smed_v6_17586_0_1, dd_Smed_v6_17586_0_1, [Score=323, Expect=4e-107]} {RNA1509_41017} {RNA1310_13859.1} {RNA815_18063}

Mlig455_023116 {REF} {Length: 3009} {Pfam: Ion channel [PF07885.18, score=122.1]; Sodium ion transport-associated [PF06512.15, score=19.2]} {Human: ENSG00000186795, KCNK18, potassium two pore domain channel subfamily K member 18, [Score=100, Expect=2e-22]; ENSG00000164626, KCNK5, potassium two pore domain channel subfamily K member 5, [Score=95.1, Expect=2e-20]} {Mouse: ENSMUSG00000040901, Kcnk18, potassium channel, subfamily K, member 18, [Score=106, Expect=1e-24]} {Dmel: FBgn0033257, sand, sandman, [Score=149, Expect=3e-40]} {Celegans: WBGene00010784, twk-48, TWiK family of potassium channels, [Score=159, Expect=4e-44]} {Smed: dd_Smed_v6_17586_0_1, dd_Smed_v6_17586_0_1, [Score=325, Expect=1e-107]} {RNA1509_41017} {RNA1310_13859.1, RNA1509_41017} {RNA1509_41017, RNA815_18063}
8. MligTC455_29921 18 0.37 Mlig455_062698

Neo: -

Age: -

 0.974 - - - - 0.974 - Mlig455_062698 {REF} {Length: 3416} {RNA1509_12781} {RNA1310_63.1} {RNA815_23.1}
9. MligTC455_21693 48 1 Mlig455_024307, Mlig455_024362, Mlig455_024476

Neo: -

Age: -

 AHR 0.97 - - 0.970 - - -

Mlig455_024307 {REF} {Length: 4440} {Pfam: PAS fold [PF08447.14, score=59.6]; PAS fold [PF00989.27, score=42.5]; PAS domain [PF14598.8, score=40.5]; PAS domain [PF13426.9, score=18.9]; C-terminal region of eIF3h [PF19445.1, score=18.6]} {Human: ENSG00000106546, AHR, aryl hydrocarbon receptor, [Score=229, Expect=8e-64]; ENSG00000283321, AC019117.2, novel protein, [Score=228, Expect=1e-63]} {Mouse: ENSMUSG00000019256, Ahr, aryl-hydrocarbon receptor, [Score=216, Expect=2e-59]} {Dmel: FBgn0003513, ss, spineless, [Score=303, Expect=7e-91]} {Celegans: WBGene00000096, ahr-1, Aryl hydrocarbon receptor protein 1, [Score=200, Expect=8e-56]} {Smed: dd_Smed_v6_17534_0_1, dd_Smed_v6_17534_0_1, [Score=369, Expect=4e-118]} {RNA1310_45588}

Mlig455_024362 {REF} {Length: 4404} {Pfam: PAS fold [PF08447.14, score=59.5]; PAS fold [PF00989.27, score=43.6]; PAS domain [PF14598.8, score=41.4]; Helix-loop-helix DNA-binding domain [PF00010.28, score=27.4]; C-terminal region of eIF3h [PF19445.1, score=20.1]} {Human: ENSG00000106546, AHR, aryl hydrocarbon receptor, [RH, Score=298, Expect=1e-88]; ENSG00000283321, AC019117.2, novel protein, [RH, Score=297, Expect=2e-88]} {Mouse: ENSMUSG00000019256, Ahr, aryl-hydrocarbon receptor, [RH, Score=286, Expect=2e-84]} {Dmel: FBgn0003513, ss, spineless, [RH, Score=398, Expect=1e-124]} {Celegans: WBGene00000096, ahr-1, Aryl hydrocarbon receptor protein 1, [RH, Score=265, Expect=6e-79]} {Smed: dd_Smed_v6_17534_0_1, dd_Smed_v6_17534_0_1, [RH, Score=503, Expect=4e-169]} {RNA1310_45588}

Mlig455_024476 {REF} {Length: 4767} {Pfam: PAS fold [PF08447.14, score=58.8]; PAS fold [PF00989.27, score=41.6]; PAS domain [PF14598.8, score=40.1]; Helix-loop-helix DNA-binding domain [PF00010.28, score=27.1]} {Human: ENSG00000106546, AHR, aryl hydrocarbon receptor, [Score=230, Expect=4e-63]; ENSG00000283321, AC019117.2, novel protein, [Score=229, Expect=4e-63]} {Mouse: ENSMUSG00000019256, Ahr, aryl-hydrocarbon receptor, [Score=217, Expect=8e-59]} {Dmel: FBgn0003513, ss, spineless, [Score=303, Expect=5e-89]} {Celegans: WBGene00000096, ahr-1, Aryl hydrocarbon receptor protein 1, [Score=199, Expect=1e-54]} {Smed: dd_Smed_v6_17534_0_1, dd_Smed_v6_17534_0_1, [Score=373, Expect=3e-117]} {RNA1310_45588}
10. MligTC455_48435 85 1.77 Mlig455_011328

Neo: -

Age: -

 0.968 - - 0.968 - - - Mlig455_011328 {REF} {Length: 1209} {Pfam: F5/8 type C domain [PF00754.27, score=25.9]} {Smed: dd_Smed_v6_83746_0_1, dd_Smed_v6_83746_0_1, [Score=51.6, Expect=2e-08]} {RNA1310_39626.1} {RNA815_20659}
11. MligTC455_12812 58 1.21 Mlig455_027688, Mlig455_047749

Neo: -

Age: Up-Down-Down

 0.965 - - 0.965 - - -

Mlig455_027688 {REF} {Length: 2289} {Pfam: Unstructured region C-term to UIM in Ataxin3 [PF16619.7, score=18.6]} {RNA1509_59038} {RNA1310_64936.1, RNA1509_59038}

Mlig455_047749 {REF} {Length: 2332} {RNA1509_59038} {RNA1310_67234}
12. MligTC455_37109 33 0.68 Mlig455_060876

Neo: -

Age: -

 0.965 - - 0.965 - - - Mlig455_060876 {REF} {Length: 929} {NoTransDecoderORF} {RNA1310_114871}
13. MligTC455_52483 36 0.76 Mlig455_042704

Neo: -

Age: -

 0.965 - - 0.965 - - - Mlig455_042704 {REF} {Length: 2647} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=149.0]} {Smed: dd_Smed_v6_31771_0_1, dd_Smed_v6_31771_0_1, [Score=71.2, Expect=7e-13]} {RNA1310_47540} {RNA815_16144}
14. MligTC455_36415 57 1.19 Mlig455_036427, Mlig455_054598

Neo: -

Age: -

 0.964 - - - - 0.964 -

Mlig455_036427 {REF} {Length: 744} {NoTransDecoderORF} {RNA1310_147078}

Mlig455_054598 {REF} {Length: 1921} {Pfam: ISXO2-like transposase domain [PF12762.9, score=19.1]} {RNA1509_22299} {RNA1310_147078} {RNA815_26270}
15. MligTC455_40780 107 2.22 Mlig455_000276, Mlig455_024108, Mlig455_035730, Mlig455_058355

Neo: -

Age: -

 0.964 - - 0.964 - - -

Mlig455_000276 {REF} {Length: 1350} {RNA1310_30070} {RNA815_59383}

Mlig455_024108 {REF} {Length: 1999} {RNA1310_30070} {RNA815_59383}

Mlig455_035730 {REF} {Length: 2143} {RNA1310_30070} {RNA815_59383}

Mlig455_058355 {REF} {Length: 1365} {RNA1310_30070} {RNA815_59383}
16. MligTC455_16248 132 2.74 Mlig455_038325, Mlig455_050222, Mlig455_050231

Neo: -

Age: -

 CHRNA3 0.959 - - 0.959 - - -

Mlig455_038325 {REF} {Length: 1078} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=200.0]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=192, Expect=4e-57]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=194, Expect=7e-58]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=190, Expect=1e-56]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=206, Expect=1e-62]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=186, Expect=4e-55]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=216, Expect=5e-67]} {RNA1310_44575} {RNA815_22042}

Mlig455_050222 {REF} {Length: 2164} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=202.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=197.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=348, Expect=5e-114]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=335, Expect=4e-109]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=348, Expect=2e-114]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=343, Expect=2e-112]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=335, Expect=5e-109]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=397, Expect=1e-133]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=338, Expect=2e-110]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=489, Expect=5e-170]} {RNA1310_44575} {RNA815_22042}

Mlig455_050231 {REF} {Length: 2219} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=203.3]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=143.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=304, Expect=5e-99]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=299, Expect=8e-97]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=293, Expect=2e-94]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=290, Expect=7e-92]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=302, Expect=3e-98]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=296, Expect=3e-96]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=291, Expect=5e-94]} {Dmel: FBgn0000036, nAChRalpha1, nicotinic Acetylcholine Receptor alpha1, [Score=352, Expect=8e-117]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=303, Expect=5e-99]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=424, Expect=2e-146]} {RNA1310_44575} {RNA815_22042}
17. MligTC455_32173 219 4.57 Mlig455_031549

Neo: -

Age: -

Region-enriched R5: 2.002/0.00002

 0.958 - - - - 0.958 - Mlig455_031549 {REF} {Length: 976} {Pfam: Cupin domain [PF07883.13, score=42.6]; AraC-like ligand binding domain [PF02311.21, score=20.4]} {RNA1509_21844} {RNA1310_48404} {RNA815_27700}
18. MligTC455_39064 110 2.28 Mlig455_000222, Mlig455_058480

Neo: Irradiation

Age: -

Region-enriched R2: 5.418/0.00017

 OSBPL1A 0.957 - - 0.957 - - -

Mlig455_000222 {REF} {Length: 2113} {Pfam: Oxysterol-binding protein [PF01237.20, score=414.5]} {Human: ENSG00000141447, OSBPL1A, oxysterol binding protein like 1A, [RH, Score=375, Expect=2e-116]; ENSG00000130703, OSBPL2, oxysterol binding protein like 2, [RH, Score=357, Expect=8e-115]} {Mouse: ENSMUSG00000044252, Osbpl1a, oxysterol binding protein-like 1A, [RH, Score=378, Expect=4e-122]; ENSMUSG00000039050, Osbpl2, oxysterol binding protein-like 2, [RH, Score=367, Expect=6e-119]} {Dmel: FBgn0034951, CG3860, [RH, Score=409, Expect=1e-135]} {Celegans: WBGene00008832, obr-2, Oxysterol Binding protein (OSBP) Related, [RH, Score=239, Expect=3e-71]} {Smed: dd_Smed_v6_3179_0_1, dd_Smed_v6_3179_0_1, [RH, Score=385, Expect=3e-126]} {RNA1509_29630} {RNA1310_38654} {RNA815_7740}

Mlig455_058480 {REF} {Length: 2888} {TRANSSPLICED} {Pfam: Oxysterol-binding protein [PF01237.20, score=414.5]} {Human: ENSG00000141447, OSBPL1A, oxysterol binding protein like 1A, [RH, Score=375, Expect=2e-116]; ENSG00000130703, OSBPL2, oxysterol binding protein like 2, [RH, Score=357, Expect=8e-115]} {Mouse: ENSMUSG00000044252, Osbpl1a, oxysterol binding protein-like 1A, [RH, Score=378, Expect=4e-122]; ENSMUSG00000039050, Osbpl2, oxysterol binding protein-like 2, [RH, Score=367, Expect=6e-119]} {Dmel: FBgn0034951, CG3860, [RH, Score=409, Expect=1e-135]} {Celegans: WBGene00008832, obr-2, Oxysterol Binding protein (OSBP) Related, [RH, Score=239, Expect=3e-71]} {Smed: dd_Smed_v6_3179_0_1, dd_Smed_v6_3179_0_1, [RH, Score=385, Expect=3e-126]} {RNA1509_29630} {RNA1310_38654} {RNA815_26411}
19. MligTC455_17520 34 0.71 Mlig455_022340

Neo: -

Age: -

 0.954 - - 0.954 - - - Mlig455_022340 {REF} {Length: 878} {Pfam: WSC domain [PF01822.21, score=52.4]; PAN domain [PF00024.28, score=24.0]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=50.4, Expect=3e-07]} {RNA1509_43359} {RNA1310_27550.1} {RNA815_22520}
20. MligTC455_06774 13 0.28 Mlig455_032313

Neo: -

Age: -

 0.953 - - - - 0.953 - Mlig455_032313 {REF} {Length: 688} {RNA1509_2515} {RNA1310_5479.2} {RNA815_3258.1}
21. MligTC455_09368 14 0.3 Mlig455_055483

Neo: -

Age: -

 0.953 - - - - 0.953 - Mlig455_055483 {REF} {Length: 459} {NoTransDecoderORF} {RNA1310_63892}
22. MligTC455_33353 166 3.46 Mlig455_007629, Mlig455_058320

Neo: -

Age: -

 0.953 - - 0.953 - - -

Mlig455_007629 {REF} {Length: 1589} {TRANSSPLICED} {Pfam: GIY-YIG catalytic domain [PF01541.26, score=24.4]} {Smed: dd_Smed_v6_129_2_1, dd_Smed_v6_129_2_1, [Score=46.2, Expect=3e-06]} {RNA1509_36216} {RNA1310_50399.2} {RNA815_22235.1}

Mlig455_058320 {REF} {Length: 184} {NoTransDecoderORF} {RNA1310_73857} {RNA815_48208}
23. MligTC455_18579 143 2.97 Mlig455_047208, Mlig455_048469

Neo: -

Age: -

 GRIK2, GRIK3 0.951 - - 0.951 - - -

Mlig455_047208 {REF} {Length: 5413} {Pfam: Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=92.5]; Ligand-gated ion channel [PF00060.28, score=84.4]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=49.2]} {Human: ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=194, Expect=2e-50]; ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=193, Expect=5e-50]; ENSG00000105737, GRIK5, glutamate ionotropic receptor kainate type subunit 5, [Score=192, Expect=2e-49]; ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=192, Expect=2e-49]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=191, Expect=3e-49]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=194, Expect=1e-50]; ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=194, Expect=3e-50]; ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=191, Expect=2e-49]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=191, Expect=2e-49]; ENSMUSG00000003378, Grik5, glutamate receptor, ionotropic, kainate 5 (gamma 2), [Score=188, Expect=2e-48]} {Dmel: FBgn0038837, CG3822, [Score=185, Expect=9e-48]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=200, Expect=7e-53]} {Smed: dd_Smed_v6_17503_0_1, dd_Smed_v6_17503_0_1, [Score=341, Expect=5e-106]} {RNA1509_47157} {RNA1310_18671} {RNA815_30308}

Mlig455_048469 {REF} {Length: 3740} {Pfam: Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=95.9]; Ligand-gated ion channel [PF00060.28, score=82.2]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=51.5]} {Human: ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=190, Expect=6e-50]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=187, Expect=5e-49]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=185, Expect=3e-48]; ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=184, Expect=1e-47]} {Mouse: ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=189, Expect=7e-50]; ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=187, Expect=6e-49]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=185, Expect=2e-48]; ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=183, Expect=9e-48]} {Dmel: FBgn0038837, CG3822, [Score=183, Expect=4e-48]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=183, Expect=3e-48]} {Smed: dd_Smed_v6_17503_0_1, dd_Smed_v6_17503_0_1, [Score=338, Expect=6e-108]} {RNA1509_47157} {RNA1310_18671} {RNA815_30308}
24. MligTC455_16305 45 0.93 Mlig455_005717

Neo: -

Age: -

 0.95 - - 0.950 - - - Mlig455_005717 {REF} {Length: 1504} {Pfam: Protein of unknown function (DUF4532) [PF15046.8, score=28.1]} {RNA1310_54208} {RNA815_57875}
25. MligTC455_25036 249 5.18 Mlig455_013396

Neo: -

Age: -

 TRIM23 0.95 - - - - 0.950 - Mlig455_013396 {REF} {Length: 2515} {TRANSSPLICED} {Pfam: ADP-ribosylation factor family [PF00025.23, score=202.8]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=45.9]; Ras family [PF00071.24, score=42.2]; B-box zinc finger [PF00643.26, score=30.5]; Signal recognition particle receptor beta subunit [PF09439.12, score=29.4]; G-protein alpha subunit [PF00503.22, score=26.1]; Gtr1/RagA G protein conserved region [PF04670.14, score=22.6]; zinc-RING finger domain [PF14634.8, score=20.2]} {Human: ENSG00000113595, TRIM23, tripartite motif containing 23, [RH, Score=488, Expect=1e-166]} {Mouse: ENSMUSG00000021712, Trim23, tripartite motif-containing 23, [RH, Score=493, Expect=2e-168]} {Dmel: FBgn0010348, Arf79F, ADP ribosylation factor at 79F, [Score=184, Expect=7e-55]} {Celegans: WBGene00000180, arc-1, E3 ubiquitin-protein ligase arc-1, [RH, Score=309, Expect=7e-98]} {Smed: dd_Smed_v6_641_0_1, dd_Smed_v6_641_0_1, [Score=183, Expect=2e-54]} {RNA1509_18100} {RNA1310_4744, RNA1509_18100} {RNA1509_18100, RNA815_9120}

Refine r cutoff to:    Show

Berezikov Lab - 2020-2021 © ERIBA